ALBANY, N.Y., March 22, 2017 /PRNewswire/
-- AMRI (NASDAQ: AMRI), a global contract research,
development and manufacturing organization that has been working
with the life sciences industry to improve patient outcomes and
quality of life for more than 25 years, has been recognized for its
excellence as a contract manufacturing organization (CMO). AMRI
has been honored as part of the Life Science Leader's 2017
CMO Leadership Awards in five categories — capabilities,
compatibility, expertise, quality and reliability.
"Competing with more than 80 contract manufacturers, AMRI is
honored to be recognized by our customers from industry pharma and
biopharma companies," said William S.
Marth, president and CEO, AMRI. "We have made several
acquisitions that have increased our strength and scale, invested
in our core legacy businesses and have grown to more than 3,000
employees globally. This growth, coupled with expanded services –
including extractables and leachables, sterile APIs and pre-filled
syringes – solidly positions us to continue to deliver development
and manufacturing services, regardless of project size and
complexity."
The CMO Leadership Awards are presented annually by Life Science
Leader, with winners chosen based on research conducted by Industry
Standard Research. The CMO Leadership Awards ensure that quality
ratings come from companies that have worked with the CMO within
the last 18 months and that results are backed by experiential
data.CMOs were eligible to win recognition from up to three groups
of respondents: big pharma, small pharma and overall (combined big
and small pharma). AMRI earned recognition from all three
groups.
"Each year, the CMO Leadership Awards recognize the success that
individual drug development and manufacturing organizations have in
serving the needs of their biotechnology and pharmaceutical
customers and partners," said Louis
Garguilo, executive editor of Life Science Leader magazine
and OutsourcedPharma.com. "An award in any of the categories adds
to the distinction and reputation of CMOs within the greater drug
discovery, development, manufacturing and marketing
industries."
To learn more about AMRI's capabilities, visit
amriglobal.com.
About AMRI
AMRI is a global contract research and
manufacturing organization that has been working with the life
sciences industry to improve patient outcomes and the quality of
life for more than two decades. With locations in North
America, Europe and Asia, our key business segments
include Discovery and Development Services (DDS), Active
Pharmaceutical Ingredients (API), Drug Product (DP), and Fine
Chemicals. For more information about AMRI, please visit our
website at www.amriglobal.com or follow us on Twitter
(@amriglobal).
SOURCE AMRI